Gene · 4172
Papers2,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,183
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Decade of Discovery-Eukaryotic Replisome Disassembly at Replication Termination. | Biology (Basel) | 2024 | 38666845 | PubTator, text mining | PubMed |
| Surveying biomedical relation extraction: a critical examination of current datasets and the proposal of a new resource. | Brief Bioinform | 2024 | 38609331 | PubTator, text mining | PubMed |
| LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3. | Cancer Lett | 2024 | 38521199 | PubTator, text mining | PubMed |
| Preparation of hepatocellular carcinoma mRNA vaccines based on potential tumor targets and immunophenotypes. | Transl Cancer Res | 2024 | 38410201 | PubTator, text mining | PubMed |
| Quantifying Landscape-Flux via Single-Cell Transcriptomics Uncovers the Underlying Mechanism of Cell Cycle. | Adv Sci (Weinh) | 2024 | 38353329 | PubTator, text mining | PubMed |
| RNF125‑mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells. | Oncol Lett | 2024 | 38298426 | PubTator, text mining | PubMed |
| RNA-seq analysis reveals modulation of inflammatory pathways by an enriched-triterpene natural extract in mouse and human macrophage cell lines. | Heliyon | 2024 | 38293365 | PubTator, text mining | PubMed |
| Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. | Int J Mol Sci | 2024 | 38279263 | PubTator, text mining | PubMed |
| Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. | Invest Ophthalmol Vis Sci | 2024 | 38231525 | PubTator, text mining | PubMed |
| A novel upregulated hsa_circ_0032746 regulates the oncogenesis of esophageal squamous cell carcinoma by regulating miR-4270/MCM3 axis. | Hum Genomics | 2024 | 38200573 | PubTator, text mining | PubMed |
| Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells. | Redox Biol | 2024 | 38184997 | PubTator, text mining | PubMed |
| Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. | Commun Biol | 2024 | 38172218 | PubTator, text mining | PubMed |
| Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. | Nat Commun | 2024 | 38167338 | PubTator, text mining | PubMed |
| Rapid conversion of porcine pluripotent stem cells into macrophages with chemically defined conditions. | J Biol Chem | 2024 | 38097188 | PubTator, text mining | PubMed |
| Immunohistochemical Comparison of Ki-67 and MCM-3 in Odontogenic Cysts: An Observational Study. | Appl Immunohistochem Mol Morphol | 2024 | 38062794 | PubTator, text mining | PubMed |
| Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine. | Genes Dis | 2024 | 37692482 | PubTator, text mining | PubMed |
| Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-MYC, and FOXM1 in human cervical carcinoma Hela cells. | J Biochem Mol Toxicol | 2024 | 37681557 | PubTator, text mining | PubMed |
| Systematic analysis of expression and prognostic significance for MCM family in head and neck squamous cell carcinoma. | Histol Histopathol | 2024 | 37526267 | PubTator, text mining | PubMed |
| Expression analysis of cyclin D, Ki-67, MCM3 and MCM2 in oral squamous cell carcinoma. | Bioinformation | 2023 | 38415027 | PubTator, text mining | PubMed |
| Role of proliferative markers in assessing recurrences in surgical margins of oral squamous cell carcinoma: A systematic review. | J Oral Maxillofac Pathol | 2023 | 38304496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4172/papers?page=4